Grant funding is capital awarded under competitive or formula programs—typically non-repayable and non-equity—to advance work aligned with a sponsor’s mission.

How it works

Sources include federal agencies (SBIR/STTR in the US, Horizon Europe, defense innovation units), state economic development offices, and philanthropic foundations. Applicants submit proposals with budgets, milestones, and team credentials. Awards may be cost-reimbursement—spend first, invoice later—or upfront tranches tied to reporting. Compliance includes allowable expenses, audit trails, and sometimes domestic manufacturing or open-data requirements. IP terms range from company-friendly to government march-in rights in rare cases. Grants pair well with early R&D-heavy startups in biotech, climate, and deep tech before institutional equity.

Why it matters

• Founders: Treat grants as project finance with paperwork overhead. Hire grant-aware finance ops or consultants for first awards.
• Investors: Non-dilutive capital improves runway efficiency but delays from reimbursement and scope limits can distract from commercial GTM.

Common mistake

Booking grant revenue before understanding reimbursement timing—cash lag can create surprise runway gaps.

Related ideas

Non-dilutive capital, SBIR, convertible note stack, government contracts, and R&D tax credits.